SECTION 1: Notwithstanding any general or special law to the contrary, the department of public health shall promulgate regulations relative to the use of buprenorphine and its variants in the treatment of opioid dependence. Said regulations shall include, but not be limited to: requiring prescribing entities to conduct routine toxicology screens of clients, pill call-backs, maximum take-home dosages, and any other regulations deemed necessary to limit diversion of buprenorphine and its variants.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.